Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1004 results for "fda"

BRIEF-FDA takes action against 4 companies for illegal sales o...

Dec 9 (Reuters) - Food and Drug Administration * U.S. FDA takes action against four tobacco manufacturers for illegal sales of flavored cigarettes labeled as little cigars or cigars * Issued warning to cos for selling flavored ... Reuters Africa, 6 minutes ago

7,060 images for fda, 1 day ago
PharmaVOICE, 1 day ago
Salon, 1 day ago
Cancer Therapy Advisor, 1 day ago
WorldNetDaily, 2 days ago, 1 day ago
MassDevice, 12 minutes ago
Inside UL -, 2 days ago
Business Today India, 1 day ago
Venture Capital Post, 2 days ago

FDA accepts AstraZeneca's marketing application for durvalumab for bladder cancer; shares up 4%

The FDA accepts under Priority Review AstraZeneca's ( AZN +3.7%) Biologics License Application (BLA) seeking approval of durvalumab for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed ...
 Seeking Alpha42 minutes ago FDA Accepts First BLA For Astrazeneca's Durvalumab In Bladder Cancer  RTTNews.com2 hours ago ASTRAZENECA : FDA Accepts License Application for Durvalumab  4 Traders2 hours ago FDA accepts durvalumab for BLA in bladder cancer  MoneyAM2 hours ago

BRIEF-Astrazeneca says durvalumab gets FDA's priority review status in bladder cancer

n"Dec 9 Astrazeneca Plc : * US FDA has accepted first biologics license application for durvalumab * US FDA granted priority review status with a prescription drug user fee act (PDUFA) set for Q2 of 2017. * Currently has more than 30 ongoing ...
 Reuters UK2 hours ago US FDA accepts first biologics license application for Astra's durvalumab  Selftrade Investments2 hours ago ASTRAZENECA : US FDA accepts first biologics license application for AstraZeneca's durvalumab in bladder cancer  4 Traders2 hours ago

What Philip Morris International's FDA Application Means for iQOS

Tobacco giant Philip Morris International ( NYSE:PM ) has been a key player in the global tobacco market for years, and it has impressive market share in selling cigarettes in dozens of countries around the world. But to an even greater extent than ...
 Motley Fool2 hours ago

TOP NEWS: AstraZeneca Receives FDA Priority Status For Durvalumab

LONDON (Alliance News) - Drugmaker AstraZeneca PLC on Friday said the US Food & Drug Administration have granted durvalumab priority review status and accepted the first biologics licence application for the drug. The application submission, for ...
 London Stock Exchange2 hours ago
Before It's News

Why Donald Trump's Putative FDA Pick Could Scare Pharma

Yesterday, Bloomberg reported that Donald Trump is considering nominating venture capitalist and libertarian Jim ONeill to head the Food and Drug Administration, and some in the pharmaceutical industry experienced an increasingly strong sense of ...
 Forbes.com1 day ago Reactions to Trump FDA Chief Rumor: Unmitigated, and Unsupported, Fear of a Libertarian Planet  Before It's News15 hours ago Why s Putative FDA Pick Could Scare Pharma  BioSpace9 minutes ago

FDA Makes the Right Move on Making Hearing Aids more Accessible, Says CTA

The following statement is attributed to Gary Shapiro, president and CEO, Consumer Technology Association (CTA) TM , regardingthe U.S. Food and Drug Administration's (FDA) announcement on that it will allow the sale of most hearings aids without a ...
 4 Traders49 minutes ago

Sun Pharma gets US FDA warning letter for Halol facility

The US Food and Drug Administration (FDA) inspected the Sun Pharma's Halol facility in Gujarat from November 17, 2016 through December 1, 2016. At the conclusion of the inspection, the US FDA issued a Form-483, citing nine inspectional observations.
 PharmaBiz9 hours ago Sun Pharma says US FDA made 9 observations at Halol unit  Livemint.com1 day ago Gilead Sciences submits NDA to FDA for once-daily triple combo HCV pill  Pharmaceutical Business Review4 hours ago US FDA listed 9 observations in notice of concerns over Halol plant: Sun Pharma  Smart Investor1 day ago
Targeted Oncology

US FDA approves Roche's Avastin plus chemotherapy for platinum-sensitive recurrent ovarian cancer

Roche announced that the US Food and Drug Administration (FDA) has approved Avastin (bevacizumab), either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone, for ...
 PharmaBiz12 hours ago BRIEF-Roche says Avastin receives FDA approval for platinum-sensitive ovarian cancer  Reuters UK2 days ago FDA approves expansion of Avastin in ovarian cancer  Formulary Journal1 day ago BRIEF-Genentech- says U.S. FDA has approved Avastin Bevacizumab  Reuters UK2 days ago
Convenience Store News

Philip Morris International seeks FDA approval to sell alternative cigarette

(MarketLine via COMTEX News Network) -- Philip Morris International has filed an application with the US Food and Drug Administration (FDA) to market a new type of cigarette as potentially less harmful compared to conventional cigarettes. The ...
 PredictWallStreet10 hours ago Philip Morris (PM) Seeks FDA Approval for IQOS Products  Zacks.com1 day ago Philip Morris Files FDA Application for Heat-Not-Burn  Convenience Store News2 days ago PHILIP MORRIS INTERNATIONAL : Company seeks to sell new cigarette Philip Morris International seeks FDA approval for "modified risk" tobacco product Philip Morris files FDA application to market alternative vapor device  4 Traders2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less